Prescriptions of biosimilars in 2021 increase to two-thirds

The share of biosimilars in daily therapy doses continued to rise last year. For substances for which biosimilars are available, the average share of biosimilars in Germany increased to 66.3%. The use of biosimilars saved around EUR 1.5 billion in 2021.

Further figures, data and analyses can be found here:
https://probiosimilars.de/publikationen/biosimilars-in-zahlen/